LDLR and familial hyperaldosteronism: FH patients predominantly carry mutations in the following genes: the low-density lipoprotein receptor (LDLR), apolipoprotein B (APOB), and proprotein convertase subtilisin/kexin type 9 (PCSK9) (Chora et al., 2022; Di Taranto et al., 2020).